Clinical Trial Detail

NCT ID NCT04100018
Title A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer (CheckMate 7DX)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Bristol-Myers Squibb

prostate adenocarcinoma


Docetaxel + Nivolumab + Prednisone

Docetaxel + Prednisone

Age Groups: adult senior

No variant requirements are available.